Stoma Site Leakage Clinical Trial
— CP343Official title:
A Randomized, Controlled Clinical Investigation of an Improved Two-piece Stoma Product for People Living With a Stoma
NCT number | NCT05652010 |
Other study ID # | CP343 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | February 1, 2023 |
Est. completion date | August 21, 2023 |
Verified date | December 2022 |
Source | Coloplast A/S |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Open-label, randomized, controlled, comparative, cross-over study with 2 test sequences comparing a new 2p coupling system with SenSura Mio Click.
Status | Completed |
Enrollment | 51 |
Est. completion date | August 21, 2023 |
Est. primary completion date | August 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Has given written consent to participate by signing the Informed Consent Signature Form 2. Be at least 18 years of age and have full legal capacity 3. Is able to handle (apply, remove, cut, etc.) the product and do the assessments themselves 4. Has an ileostomy or colostomy with consistent liquid fecal output (for colostomy: 6-7 Bristol stool scale*) *See appendix 1 5. Currently use SenSura Mio Click 2p Click flat or concave with 50 mm coupling size 6. Have had their ostomy for at least 90 days 7. Be willing to change the bag at least twice per week 8. Is willing and suitable (determined by the Principal Investigator or designee) to use flat or concave 2p open product during the investigation 9. Is willing to use 2p maxi open bags during the investigation Exclusion Criteria: 1. Is currently receiving or have within the past 60 days received radio-and/or chemotherapy - low doses radio- and/or chemotherapy (assessed by Principal Investigator) is allowed for indications other than cancer. 2. Is currently receiving or have within the past 30 days received topical steroid treatment in the peristomal skin area, e.g., lotion or spray - Low dose systemic steroid treatment (e.g., inhalation) assessed by the investigator are allowed. - Other systemic steroid treatment (e.g., injection or tablet) are not allowed. 3. Is pregnant and/or breast-feeding 4. Have a loop ileostomy 5. Is currently using convex baseplate 6. Has known hypersensitivity towards any of the products used in the investigation |
Country | Name | City | State |
---|---|---|---|
United States | American Health Research | Charlotte | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Coloplast A/S |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Coupling Leakage | Leakage through coupling registered at each bag change (yes/no). | 3 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04763863 -
The Nordic Consensus Study
|
||
Terminated |
NCT04802538 -
Performance and Safety of a Novel Ostomy Ring to Improve Ileostomy and Colostomy Management
|
N/A | |
Completed |
NCT04544566 -
A Clinical Pilot Study of Newly Developed Ostomy Tapes and How They Adhere to the Skin
|
N/A |